" Clearly the combo didn’t cut the mustard."
The supply agreement for the combination trial between HER-Vaxx and pembrolizumap was only announced in March 2022. And the combo trial never actually commenced.
- Forums
- ASX - By Stock
- Media
" Clearly the combo didn’t cut the mustard." The supply...
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $468.4M |
Open | High | Low | Value | Volume |
30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 199923 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 61702 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3760 | 0.345 |
11 | 19799 | 0.340 |
7 | 103625 | 0.330 |
2 | 35000 | 0.325 |
3 | 108300 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 123868 | 3 |
0.305 | 1039 | 1 |
0.310 | 38374 | 5 |
0.325 | 59531 | 3 |
0.330 | 179497 | 6 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online